Loading chat...

PA SB402

Bill

Status

Introduced

3/6/2025

Primary Sponsor

David Argall

Click for details

Origin

Senate

2025-2026 Regular Session

AI Summary

  • Allows school districts and charter schools to voluntarily participate in a program where trained nonmedical employees can administer emergency anti-seizure medication (nasal sprays, vagus nerve stimulator magnets, and other FDA-approved non-rectal treatments) to students with epilepsy when no nurse is available on-site.

  • Requires volunteer employees to receive training from licensed health care professionals, with retraining required if they haven't administered medication within two years; employees cannot be coerced to volunteer and may rescind their participation with appropriate notice.

  • Parents or guardians must submit written authorization requesting emergency medical assistance for their child, along with a health care provider statement detailing the student's medication, dosage, seizure symptoms, and post-seizure observation protocols.

  • Schools participating in the program receive civil liability immunity for good faith actions and must provide defense and indemnification to volunteer employees; schools must also compensate volunteers if emergency administration requires work beyond scheduled hours.

  • Department of Education must develop and publish training guidelines by December 31, 2025, in consultation with the U.S. Department of Health and Human Services, and maintain a clearinghouse of best practices on its website.

Legislative Description

Providing for administration of emergency anti-seizure medication.

Last Action

First consideration

3/23/2026

Committee Referrals

Education3/6/2025

Full Bill Text

No bill text available